Delix Therapeutics, Inc.

UEI
NYWDNH5MPR28
CAGE
92L09
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Delix Therapeutics, Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Development of small-molecule treatment for hearing loss Grant · HT94252410608 Defense Health Agency $825,000
Determination of route of administration and cardiac safety of a novel psychoplastogen for the treatment of suds -… Grant · R43DA059054 National Institute on Drug Abuse $449,736

Quick answers

What is Delix Therapeutics, Inc.'s UEI?

Delix Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is NYWDNH5MPR28.

What is Delix Therapeutics, Inc.'s CAGE code?

Delix Therapeutics, Inc.'s CAGE code is 92L09.

What is Delix Therapeutics, Inc.'s primary NAICS code?

Delix Therapeutics, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Is Delix Therapeutics, Inc. registered in SAM.gov?

Delix Therapeutics, Inc.'s SAM.gov registration expired on July 30, 2025.

What is Delix Therapeutics, Inc.'s most recent federal award?

Delix Therapeutics, Inc.'s most recent federal grant award is Development of small-molecule treatment for hearing loss (HT94252410608), from Defense Health Agency, on June 1, 2024.

On GovTribe

See Delix Therapeutics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login